Element Biosciences Inc., developer of a new and disruptive DNA sequencing platform, has partnered with Genoox, a community-driven genomic data platform, to demonstrate the clinical potential of the AVITI system for rare and undiagnosed disease research, using whole genome sequencing.   An initial study, in collaboration with Dr. Radha Ayyagari, professor of Ophthalmology and Pathology at the Shiley Eye Institute, UC San Diego, utilized the AVITI platform to sequence DNA from 10 individuals wi...